Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

28.8K views

Cited by 28

08:35 min

January 4th, 2012

10.3791/3612-v

January 4th, 2012

28.8K views

Type B gelatin-based engineered nanovectors system (GENS) was developed for systemic gene delivery and transfection in the treatment of pancreatic cancer. By modification with epidermal growth factor receptor (EGFR) specific peptide on the surface of nanparticles, they could target on EGFR receptor and release plasmid under reducing environment, such as high intracellular glutathione concentrations.

Explore More Videos

EGFR Targeted Nanoparticles

Chapters in this video

0:05

Title

1:29

Preparation of Plasmid DNA Encapsulated EGRF-targeted Gelatin Nanoparticles

5:28

Determination of Transfection Efficiency by Fluorescence Microscopy

7:15

Quantitative Determination of Therapeutic Efficiency with Plasmid-encapsulated Nanoparticles

8:08

Conclusion

Related Videos